Press Releases April 20, 2026 07:50 PM

Oriental Rise Receives Nasdaq Staff Delisting Determination

Nasdaq to delist Oriental Rise following continued low share price; company plans hearing and compliance efforts

By Derek Hwang ORIS
Oriental Rise Receives Nasdaq Staff Delisting Determination
ORIS

Oriental Rise Holdings Limited received a delisting determination from Nasdaq due to its stock price remaining below $1.00 for over 30 days, and is ineligible for a compliance period due to a recent reverse stock split. The company plans to request a hearing to contest the delisting and aims to regain compliance with listing requirements, but success is uncertain.

Key Points

  • Nasdaq determined Oriental Rise's shares have been below the $1.00 minimum bid price requirement for 30 consecutive days, triggering delisting procedures.
  • The company conducted a 1-for-20 reverse stock split in late 2025, disqualifying it from the standard 180-day compliance period to regain share price eligibility.
  • Oriental Rise intends to request a hearing with the Nasdaq Hearings Panel to contest delisting and plans to present strategies to meet continued listing rules.
  • Sectors impacted: US equity markets, particularly small-cap and Chinese ADR stocks; agriculture and consumer goods related to tea products in mainland China.

NINGDE, China, April 20, 2026 (GLOBE NEWSWIRE) -- Oriental Rise Holdings Limited (NASDAQ: ORIS) (“Oriental Rise” or the “Company”), an integrated tea supplier in mainland China, today announced that it received a staff determination letter (the “Determination Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on April 15, 2026, notifying the Company that Nasdaq has determined to delist the Company’s ordinary shares from The Nasdaq Capital Market.

According to the Determination Letter, Nasdaq determined that the closing bid price of the Company’s listed securities had been below $1.00 per share for the previous 30 consecutive business days and that the Company therefore no longer complies with Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.

Nasdaq further stated that, because the Company effected a 1-for-20 reverse stock split on December 30, 2025, the Company is not eligible for the 180-calendar day compliance period that would otherwise be available under Nasdaq Listing Rule 5810(c)(3)(A).

Nasdaq has advised the Company that, unless the Company requests a hearing before a Nasdaq Hearings Panel by April 22, 2026, trading in the Company’s ordinary shares will be suspended at the opening of business on April 24, 2026, and Nasdaq will file a Form 25-NSE with the U.S. Securities and Exchange Commission to remove the Company’s securities from listing and registration on The Nasdaq Stock Market.

The Company intends to timely request a hearing before the Nasdaq Hearings Panel. The hearing request will stay the suspension of the Company’s securities and the filing of the Form 25-NSE pending the Panel’s decision. The Company is currently evaluating its options and intends to present a plan to regain compliance with Nasdaq’s continued listing requirements.

There can be no assurance that the Hearings Panel will grant the Company’s request for continued listing or that the Company will be able to regain compliance with the applicable continued listing requirements.

About Oriental Rise Holdings Limited (NASDAQ: ORIS)

Oriental Rise Holdings Limited is an integrated supplier of tea products in mainland China. Its major tea products include primarily-processed tea consisting of white tea and black tea, as well as refined white tea and black tea. The Company’s business operations are vertically integrated, covering tea cultivation, processing of tea leaves, and the sale of tea products to tea business operators, such as wholesale distributors, and end-user retail customers in mainland China. The Company operates tea gardens located in Zherong County, Ningde City in Fujian Province of mainland China.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements, including, without limitation, statements regarding the Company’s intent to request a hearing before the Nasdaq Hearings Panel, its plans to regain compliance with Nasdaq’s continued listing requirements, and the outcome of any hearing process. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Words such as “believes,” “expects,” “intends,” “plans,” “may,” “will,” and similar expressions are intended to identify forward-looking statements.

The Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable law. Investors are cautioned that actual results may differ materially from those described in the forward-looking statements.

For investor and media inquiries, please contact:

Oriental Rise Holdings Limited
Investor Relations Department
Email: [email protected]


Risks

  • Delisting from Nasdaq would severely reduce Oriental Rise's share liquidity and investor visibility, potentially harming its capital raising ability.
  • The company’s plan to regain compliance might fail, leading to permanent removal from Nasdaq and possible listing on less liquid over-the-counter markets.
  • Market sentiment toward Chinese companies listed in the US remains cautious amid regulatory and geopolitical uncertainties, increasing overall risk for Oriental Rise investors.

More from Press Releases

Fiverr Announces First Quarter 2026 Results Apr 29, 2026 Nayax to Report 2026 Q1 Earnings on May 12, 2026 Apr 28, 2026 Xunlei Filed Its Annual Report on Form 20-F for Fiscal Year 2025 Apr 28, 2026 Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain Apr 28, 2026 Syntec Optics (Nasdaq: OPTX) Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Apr 28, 2026